News

  1. CDMO PCI Pharma Services Adds 3 Vanrx Sterile Filling Systems To Meet Industry Needs 2/3/2022

    PCI Pharma Services is pleased to announce the addition of three new exceptional automated sterile fill-finish machines in our San Diego and Melbourne facilities. Purchased from Cytiva, this remarkable equipment can pivot between filling different sterile medications into vials and syringes. The addition of these machines comes after our recent acquisition of Lyophilization Services of New England, Inc. (LSNE), specialists in the manufacturing of complex injectables for biologics and small molecules, bringing even broader capabilities to PCI clients across the entire product lifecycle and allowing them to bring their life-changing therapies to market with increased speed and safety.

  2. Global Pharmaceutical Packaging Manufacturer To Invest More Than $70 Million In Kinston Expansion 2/1/2022

    West Pharmaceutical Services, Inc. [NYSE: WST], a global leader in innovative solutions for injectable drug administration, will create approximately 70 jobs in Lenoir County, Governor Roy Cooper announced.

  3. West Announces Landmark Collaboration With Corning In Pharmaceutical Injectable Drug Delivery 1/26/2022

    The exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions.

  4. Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement To Develop AVERSA™ Fentanyl, An Abuse Deterrent Fentanyl Patch 1/10/2022

    The feasibility agreement is focused on adapting Kindeva’s commercial transdermal manufacturing process to incorporate AVERSA technology.

  5. Baxter Announces $100 Million Investment In BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility 11/11/2021

    This facility is operated by BioPharma Solutions (BPS), a business unit of Baxter that specializes in partnering with leading pharmaceutical and biotech companies on the development and contract manufacturing of drug product for parenteral (injectable) pharmaceuticals.

  6. Baxter BioPharma Solutions Announces $50 Million Investment To Expand Sterile Fill/Finish Manufacturing Site In Bloomington, Ind. 11/24/2020

    These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed.

  7. Bespak Launches New Auto Injector, Leads Workshop On Combo Product Innovation At PDA Europe 11/2/2015

    Bespak has launched the Syrina 2.25 at PDA Europe 2015. Moreover, Steven Kaufman, Global Business Development Lead at the company, will chair a 1-day specialized industry discussion on innovative combinational products at a workshop taking place during PDA Europe 2015, Universe of Pre-filled Syringes & Injection Devices in Vienna, Austria.

  8. OsoBio Appoints Dr. Paul W. Stoker Director Of Laboratories 2/24/2014

    As part of the company’s quality control department, the laboratories are responsible for testing the in-process and finished products – as well as raw materials and components – involved in OsoBio’s cGMP sterile manufacturing operations. The labs also are charged with environmental monitoring and analytical method development.

    “While continuous quality compliance is key to OsoBio’s business success, it’s even more important to the patients who rely upon the medications we manufacture – and we try to never lose sight of that fact,” said Milton Boyer, president of OsoBio. “Paul will lead a team of scientists who are knowledgeable, capable and highly committed to integrity – delivering excellence to both our clients and the patients we collectively serve.”

  9. OsoBio Reaffirms DCAT Partnership Through New Leadership Positions 12/17/2013

    OsoBio has reaffirmed its long-standing partnership with the Drug, Chemical and Associated Technologies Association (DCAT) by accepting new volunteer leadership positions within the organization.

  10. OsoBio Appoints Lindsey Pruitt To Manage East Coast Business Development Efforts 7/22/2013

    OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.